MDxHealth SA (MDXH) – Strategy, SWOT and Corporate Finance Report

MDxHealth SA (MDXH) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

MDxHealth SA (MDxHealth) develops and commercializes advanced epigenetic and other molecular tests for cancer assessment, and the personalized treatment of patients. The company’s product portfolio includes ConfirmMDx, an epigenetic assay that detects the epigenetic effect of cancer; SelectMDx, a liquid biopsy assay for prostate cancer. MdxHealth tests are based on MSP (Methylation-Specific polymerase chain reaction) technology, a proprietary DNA-based platform. It also offers biomarker development services to many pharmaceutical companies. MDxHealth markets its products through sales forces, partnerships and distributors. The company has operations in the Netherlands, Belgium, and the US. MDxHealth is headquartered in Herstal, Liege, Belgium.

Scope

• Detailed information on MDxHealth SA required for business and competitor intelligence needs

• A study of the major internal and external factors affecting MDxHealth SA in the form of a SWOT analysis

• An in-depth view of the business model of MDxHealth SA including a breakdown and examination of key business segments

• News about MDxHealth SA, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of MDxHealth SA and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess MDxHealth SA as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on MDxHealth SAs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Agendia NV

Myriad Genetics Inc

Hologic Ltd

Epigenomics AG

Genomic Health Inc

OPKO Health Inc

Beckman Coulter Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

MDxHealth SA - Key Facts

MDxHealth SA - Key Employees

MDxHealth SA - Key Employee Biographies

MDxHealth SA - Major Products and Services

MDxHealth SA - History

MDxHealth SA - Company Statement

MDxHealth SA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

MDxHealth SA - Business Description

Business Segment: License Revenue

Performance

Business Segment: Royalties

Performance

Business Segment: Service Revenue

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Rest of the World

Performance

Geographical Segment: United States of America

Performance

R&D Overview

MDxHealth SA - Corporate Strategy

MDxHealth SA - SWOT Analysis

SWOT Analysis - Overview

MDxHealth SA - Strengths

MDxHealth SA - Weaknesses

MDxHealth SA - Opportunities

MDxHealth SA - Threats

MDxHealth SA - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

MDxHealth SA, Medical Equipment, Deals By Year, 2017 to YTD 2023

MDxHealth SA, Medical Equipment, Deals By Type, 2017 to YTD 2023

MDxHealth SA, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 25, 2023: MDxHealth Announces Results of its Annual and Extraordinary General Shareholders’ Meetings

Mar 08, 2023: MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023

Feb 22, 2023: MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023

Aug 25, 2022: MDxHealth Reports Half Year 2022 Results

Aug 02, 2022: Mdxhealth Acquires Oncotype DX GPS Prostate Cancer Business from Exact Sciences and Reports Preliminary Half Year 2022 Results

Mar 02, 2022: MDxHealth Reports Financial Year 2021 Results and Provides Outlook and Guidance for 2022

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

MDxHealth SA, Key Facts

MDxHealth SA, Key Employees

MDxHealth SA, Key Employee Biographies

MDxHealth SA, Major Products and Services

MDxHealth SA, History

MDxHealth SA, Subsidiaries

MDxHealth SA, Key Competitors

MDxHealth SA, Ratios based on current share price

MDxHealth SA, Annual Ratios

MDxHealth SA, Annual Ratios (Cont…1)

MDxHealth SA, Annual Ratios (Cont…2)

MDxHealth SA, Interim Ratios

MDxHealth SA, Medical Equipment, Deals By Year, 2017 to YTD 2023

MDxHealth SA, Medical Equipment, Deals By Type, 2017 to YTD 2023

MDxHealth SA, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

MDxHealth SA, Performance Chart (2018 – 2022)

MDxHealth SA, Ratio Charts

MDxHealth SA, Medical Equipment, Deals By Year, 2017 to YTD 2023

MDxHealth SA, Medical Equipment, Deals by Type, 2017 to YTD 2023

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2960

Saved reports